HILLARY MCCONNELL: Open Payments
NPI 1598543159 · WILKES BARRE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$889 in 32 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $889
Food & beverage: $889
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $192 |
| GENZYME CORPORATION | 5 | $126 |
| BioCryst US Sales Co., LLC | 4 | $124 |
| CSL Behring | 4 | $109 |
| ARS Pharmaceuticals Operations, Inc. | 3 | $60 |
| Regeneron Healthcare Solutions, Inc. | 2 | $55 |
| GlaxoSmithKline, LLC. | 2 | $54 |
| Ionis Pharmaceuticals, Inc. | 2 | $52 |
| Amgen Inc. | 2 | $36 |
| Genentech USA, Inc. | 1 | $27 |
Products named: DUPIXENT, TEZSPIRE, ORLADEYO, Andembry, NEFFY, NUCALA, DAWNZERA, FASENRA.
Industry payments across PA — which companies pay providers there.
